Your browser doesn't support javascript.
loading
Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancer.
Li, Ran; Sant, Sneha; Brown, Emmaline; Caramia, Franco; Nikolic, Bronte; Clarke, Kylie; Byrne, Ann; Lara Gonzalez, Luis E; Savas, Peter; Luen, Stephen J; Teo, Zhi Ling; Virassamy, Balaji; Neeson, Paul J; Darcy, Phillip K; Loi, Sherene.
Affiliation
  • Li R; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Sant S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Brown E; Department of Surgery, Sir Charles Gairdner Hospital, QEII Medical Centre, Nedlands, Australia.
  • Caramia F; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Nikolic B; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Clarke K; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Byrne A; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Lara Gonzalez LE; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Savas P; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Luen SJ; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Teo ZL; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Virassamy B; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Neeson PJ; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Darcy PK; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
J Natl Cancer Inst ; 115(7): 805-814, 2023 07 06.
Article in En | MEDLINE | ID: mdl-37166471

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / B7-H1 Antigen Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / B7-H1 Antigen Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Type: Article Affiliation country: Australia